Latest filings (excl ownership)
REVOKED
Registration or securities revoked
17 Jul 19
25-NSE
Exchange delisting
18 May 16
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5 May 16
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Apr 16
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2 Mar 16
8-K/A
TPI Received Acceptance Letter From NYSE MKT Regarding its Plan of Compliance with Continued Listing Requirements
11 Jan 16
8-K/A
Other Events
23 Dec 15
8-K
TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements
2 Dec 15
NT 10-Q
Notice of late quarterly filing
17 Nov 15
8-K
TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements
19 Oct 15
8-K
Other Events
16 Oct 15
NT 10-K
Notice of late annual filing
28 Sep 15
8-K
Other Events
22 Sep 15
10-Q
2015 Q3
Quarterly report
11 Aug 15
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
11 Aug 15
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Jul 15
8-K
Entry into a Material Definitive Agreement
14 Jul 15
8-K
Submission of Matters to a Vote of Security Holders
25 Jun 15
8-K
Amendments to Articles of Incorporation or Bylaws
22 Jun 15
8-K
TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements
26 May 15
NT 10-Q
Notice of late quarterly filing
15 May 15
DEF 14A
Definitive proxy
31 Mar 15
10-Q
2015 Q2
Quarterly report
13 Mar 15
8-K
TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements
26 Feb 15
NT 10-Q
Notice of late quarterly filing
18 Feb 15
8-K/A
TPI to Form Strategic Alliance with Buchang Pharma
6 Feb 15
8-K
Departure of Directors or Certain Officers
28 Jan 15
8-K
TPI to Form Strategic Alliance with Buchang Pharma
16 Jan 15
8-K
Departure of Directors or Certain Officers
6 Jan 15
10-Q
2015 Q1
Quarterly report
31 Dec 14
10-K
2014 FY
Annual report
9 Dec 14
NT 10-Q
Notice of late quarterly filing
14 Nov 14
8-K/A
Departure of Directors or Certain Officers
27 Oct 14
8-K
Tianyin Pharmaceutical Received Notices of Non-Compliance from NYSE MKT
21 Oct 14
8-K
Departure of Directors or Certain Officers
16 Oct 14
8-K
Regulation FD Disclosure
15 Oct 14
NT 10-K
Notice of late annual filing
29 Sep 14
8-K/A
Other Events
8 Jul 14
8-K/A
Other Events
23 Jun 14
Latest ownership filings
SC 13G
Tianyin Pharmaceutical Co., Inc.
17 Feb 16
3
Yong Zhan
24 Mar 15
SC 13G
Tianyin Pharmaceutical Co., Inc.
13 Feb 15
SC 13G
Tianyin Pharmaceutical Co., Inc.
14 Feb 14
SC 13G/A
Tianyin Pharmaceutical Co., Inc.
14 Feb 14
SC 13D/A
TIME POLY MANAGEMENT, LTD.
24 Feb 12
SC 13D/A
TIME POLY MANAGEMENT, LTD.
1 Dec 11
SC 13D/A
TIME POLY MANAGEMENT, LTD.
12 Nov 10
SC 13D
Lor Stewart Shiang
15 Apr 10
SC 13D/A
TIME POLY MANAGEMENT, LTD.
14 Apr 10
SC 13D/A
CMARK HOLDINGS CO., LTD.
2 Apr 10
SC 13D/A
TIME POLY MANAGEMENT, LTD.
2 Apr 10
SC 13D/A
Lor Stewart Shiang
2 Apr 10
SC 13D/A
CMARK HOLDINGS CO., LTD.
4 Mar 10